About the Journal
JOURNAL POLICIES
ACCESS TO THE JOURNAL
The journal has the open access as well as the standard subscription based access for which the authors will not be charged.
PUBLICATION ETHICS
Authors should respect the high standards mentioned in the publication ethics as set out by the Commission on Publication Ethics (COPE)
and International Committee of Medical Journal Editors (ICMJE). Falsification or fabrication of data, plagiarism, including duplicate publication of the author's own work without proper citation, and misappropriation of the work are all forbidden practices. Any cases of ethical misconduct will be treated very seriously and will be dealt with in accordance with the COPE guidelines. If misconduct is found or suspected after the manuscript is published, the journal will retract the article.
Authorship
All authors listed on the manuscript should have contributed significantly to at least one of the step of the publication process (the experimental design, its implementation, or analysis and interpretation of the data). All authors should read and approve the final version. Any other individuals who made less substantive contributions to the article should be listed in the Acknowledgement section. Any change in authorship (including author order) after the initial article submission must be approved in writing by all authors.
Authorship and 'Umbrella' groups
Many large collaborative studies are organized under a group name which represents all the participants. Author(s) should acknowledge the umbrella group from which the data originate should first list the author(s) of the article and follow this with 'on behalf of the GROUP NAME'.
Originality
By submitting your article to the journal, you indirectly certify that this it is an original manuscript and is unpublished work and is not under consideration elsewhere. Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation is forbidden by the journal. Manuscripts submitted to the journal will be controlled with anti-plagiarism software.
Conflicts of interest
At the time of submission, each author should reveal any financial interests or connections, or other situations that might raise the question of bias in the work they have accomplished.
As part of the online submission process, corresponding authors have the task to confirm whether they or their co-authors have any conflicts of interest to declare, and in the case of an existing conflict of interest that this is fully declared.
A Conflict-of-Interest statement should be added to their submitted manuscript.
This Conflict-of-Interest information will be communicated in a statement in the published article.
EXPERIMENTAL ETHICS
Animal experiments
Regarding animal experiments, authors should indicate whether the institution’s, national research councils, or any other law on the care and use of laboratory animals was taken into taken.
Human subjects
Regarding human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration (1964, amended most recently in 2008) of the World Medical Association. Articles should include a statement that the patient’s written consent was obtained and any information, including illustrations, should be as anonymized. Authors should indicate that the design of the work has been approved by local ethical committees or that it is in conformity with the standards currently applied in the country of origin. The name of the authorizing body should be indicated in the article.
PEER REVIEW PROCESS
All submissions to the journal are first reviewed by the Editor and his Associates. At this stage, articles may be rejected without peer review if it is felt that they are not of priority or not relevant to the journal. This fast rejection process means that authors will be informed quickly and do not need to wait for the review process.
Manuscripts that are not rejected during this first step are sent out for peer review, usually to two independent reviewers. Based on the feedback from these reviewers and the Editors’ judgment a decision will be taken for the manuscript.
Manuscripts may also be sent out for statistical evaluation.
The maximum time from submission to first decision is 90 days.
DRUG DISCLAIMER
The mention of trade names, commercial products or organizations, and the inclusion of advertisements in the Journal of Humanitarian Cardiovascular Medicine does not imply endorsement by the Society, the editors, the editorial board, or the institution to which the authors are affiliated. The authors should take all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in the Journal of Humanitarian Cardiovascular Medicine. The ultimate responsibility for the use and dosage of drugs mentioned in the Journal of Humanitarian Cardiovascular Medicine and in the interpretation of published material lies with the medical practitioner and authors, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in the Journal of Humanitarian Cardiovascular Medicine. Please inform the editors of any errors.
MATERIAL DISCLAIMER
The opinions expressed in the Journal of Humanitarian Cardiovascular Medicine are those of the authors and contributors, and do not necessarily reflect those of the editors or the institution to which the authors are affiliated.
ePublisher
The National Documentation Centre (www.ekt.gr) is a national infrastructure. Since 1980, it actively engages in the collection, organization and dissemination of scientific and technological information in Greece and internationally. EKT’s strategic priority is the aggregation, organized online dissemination and preservation of quality-assured scholarly and educational content in a single research infrastructure.
EKT’s vision is “Access to Knowledge”. To this end it implements Open Access policies in research, supports the transfer and dissemination of scientific knowledge, collaborates with research, education and cultural institutions for the aggregation, organization and dissemination of digital content and provides innovative services in scientific information.
EKT provides reliable ePublishing services as part of its scholarly content aggregation and dissemination activities . Its integrated online ePublishing environment is developed with open-source interoperable technology. This affords the incorporation of EKT’s infrastructures into the continuously developing international infrastructure environment.
EKT’s ePublishing services (http://epublishing.ekt.gr/) are directed to public and extended public institution publishers of accredited scholarly journals. They include, most significantly, the organization, documentation and organized dissemination of metadata and content of scholarly journals, the training and consulting services on issues such as intellectual property, the standardization of editorial processes according to internationally accepted standards, the inclusion of content and metadata in international content indexers and harvesters via interoperable systems.
